185 related articles for article (PubMed ID: 7195239)
1. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
Stauch M; Nechwatal W
Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
[TBL] [Abstract][Full Text] [Related]
2. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
Hauf GF; Bubenheimer P; Roskamm H
Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of single-dose administration of AR-L 115 BS in patients with coronary artery disease.
Weikl A; Kohlschütter S; Durst OE; Lang E
Arzneimittelforschung; 1981; 31(1a):244-7. PubMed ID: 7195232
[TBL] [Abstract][Full Text] [Related]
4. Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction.
Nebel W; Sabin G; Surawitzki G
Arzneimittelforschung; 1981; 31(1a):251-3. PubMed ID: 7195234
[TBL] [Abstract][Full Text] [Related]
5. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
Wollschläger H; Drexler H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
[TBL] [Abstract][Full Text] [Related]
6. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals.
Diederen W; Kadatz R
Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic activity of different doses of sulmazole by infusion.
Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
[TBL] [Abstract][Full Text] [Related]
8. [The effect of AR-L 115 BS on contractility dynamics of the isolated, metabolically supported dog heart (author's transl)].
Hockerts T; Höcht B; Broll R; Trenkel K; Sieber J; Kilian A; Brendle B
Arzneimittelforschung; 1981; 31(1a):157-61. PubMed ID: 7195211
[TBL] [Abstract][Full Text] [Related]
9. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
Thormann J; Kramer W; Schlepper M
Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
[TBL] [Abstract][Full Text] [Related]
10. A new orally active positive inotropic substance: AR-L 115 BS.
Ruffmann KD; Mehmel HC; Kübler W
Arzneimittelforschung; 1981; 31(1a):271-3. PubMed ID: 7195240
[TBL] [Abstract][Full Text] [Related]
11. Ergometric and hemodynamic studies on a new cardiotonic agent AR-L 115 BS.
Pozenel H
Arzneimittelforschung; 1981; 31(1a):263-6. PubMed ID: 7195238
[TBL] [Abstract][Full Text] [Related]
12. Study of the acute effect of AR-L 115 BS, a new positive-inotropic agent in patients with exercise-induced heart failure.
Drexler H; Wollschläger H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):259-62. PubMed ID: 7195237
[TBL] [Abstract][Full Text] [Related]
13. Effects of AR-L 115 BS on hemodynamics, myocardial oxygen consumption and cardiac pumping efficiency.
Hellige G; Baller D; Ensink FB; Zipfel J; Wolpers HG; Bretschneider HJ
Arzneimittelforschung; 1981; 31(1a):155-6. PubMed ID: 7195210
[TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic effects of a new positive inotropic agent (AR-L 115 BS) in ischemic and nonischemic myocardiopathies].
Colle JP; Ohayon J; Ledain L; Besse P
Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1532-9. PubMed ID: 6440503
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
Baumann G; Ningel K; Permanetter B
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
[TBL] [Abstract][Full Text] [Related]
16. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
Diederen W; Kadatz R
Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
[TBL] [Abstract][Full Text] [Related]
17. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115 BS, a new positive inotropic agent with additional vasodilating activity, in normal subjects.
Benedikter L; Mey T
Arzneimittelforschung; 1981; 31(1a):239-42. PubMed ID: 7195230
[TBL] [Abstract][Full Text] [Related]
18. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
19. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.
Dämmgen J; Kadatz R; Diederen W
Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
Dage RC; Roebel LE; Hsieh CP; Woodward JK
J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
